Functional Role of MicroRNA/PI3K/AKT Axis in Osteosarcoma

Overview

Journal Front Oncol

Specialty Oncology

Date 2023 Jul 5

PMID 37404761

Authors

Yubo Xiang

Yingxin Yang

Jia Liu

Xu Yang

Affiliations

Soon will be listed here.

Abstract

Osteosarcoma (OS) is a primary malignant bone tumor that occurs in children and adolescents, and the PI3K/AKT pathway is overactivated in most OS patients. MicroRNAs (miRNAs) are highly conserved endogenous non-protein-coding RNAs that can regulate gene expression by repressing mRNA translation or degrading mRNA. MiRNAs are enriched in the PI3K/AKT pathway, and aberrant PI3K/AKT pathway activation is involved in the development of osteosarcoma. There is increasing evidence that miRNAs can regulate the biological functions of cells by regulating the PI3K/AKT pathway. MiRNA/PI3K/AKT axis can regulate the expression of osteosarcoma-related genes and then regulate cancer progression. MiRNA expression associated with PI3K/AKT pathway is also clearly associated with many clinical features. In addition, PI3K/AKT pathway-associated miRNAs are potential biomarkers for osteosarcoma diagnosis, treatment and prognostic assessment. This article reviews recent research advances on the role and clinical application of PI3K/AKT pathway and miRNA/PI3K/AKT axis in the development of osteosarcoma.

Citing Articles

Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications.

Hashemi M, Abolghasemi Fard A, Pakshad B, Asheghabadi P, Hosseinkhani A, Hosseini A Noncoding RNA Res. 2024; 11:1-21.

PMID: 39720352 PMC: 11665378. DOI: 10.1016/j.ncrna.2024.11.006.

Effect of Spicatoside a on Anti-Osteosarcoma MG63 Cells through Reactive Oxygen Species Generation and the Inhibition of the PI3K-AKT-mTOR Pathway.

Yun H, Kim S, Kwon Y, Park K Antioxidants (Basel). 2024; 13(10).

PMID: 39456416 PMC: 11505237. DOI: 10.3390/antiox13101162.

Crosstalk of methylation and tamoxifen in breast cancer (Review).

Shen J, He Y, Li S, Chen H Mol Med Rep. 2024; 30(4).

PMID: 39129315 PMC: 11338244. DOI: 10.3892/mmr.2024.13304.

Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review.

Mehrtabar E, Khalaji A, Pandeh M, Farhoudian A, Shafiee N, Shafiee A Med Oncol. 2024; 41(9):222.

PMID: 39120634 DOI: 10.1007/s12032-024-02469-4.

Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma.

Yun H, Kwon H, Lee J, Park K Int J Mol Sci. 2024; 25(7).

PMID: 38612399 PMC: 11012096. DOI: 10.3390/ijms25073582.

References

Maehama T, Dixon J . The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998; 273(22):13375-8. DOI: 10.1074/jbc.273.22.13375. View

Kim V, Nam J . Genomics of microRNA. Trends Genet. 2006; 22(3):165-73. DOI: 10.1016/j.tig.2006.01.003. View

Liu P, Cheng H, Roberts T, Zhao J . Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 2009; 8(8):627-44. PMC: 3142564. DOI: 10.1038/nrd2926. View

Jin B, Jin D, Zhuo Z, Zhang B, Chen K . MiR-1224-5p Activates Autophagy, Cell Invasion and Inhibits Epithelial-to-Mesenchymal Transition in Osteosarcoma Cells by Directly Targeting PLK1 Through PI3K/AKT/mTOR Signaling Pathway. Onco Targets Ther. 2020; 13:11807-11818. PMC: 7680192. DOI: 10.2147/OTT.S274451. View

Edlind M, Hsieh A . PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance. Asian J Androl. 2014; 16(3):378-86. PMC: 4023363. DOI: 10.4103/1008-682X.122876. View

Isakoff M, Bielack S, Meltzer P, Gorlick R . Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol. 2015; 33(27):3029-35. PMC: 4979196. DOI: 10.1200/JCO.2014.59.4895. View

Feng M, Yang K, Wang J, Li G, Zhang H . First Report of FARSA in the Regulation of Cell Cycle and Survival in Mantle Cell Lymphoma Cells via PI3K-AKT and FOXO1-RAG1 Axes. Int J Mol Sci. 2023; 24(2). PMC: 9865697. DOI: 10.3390/ijms24021608. View

Holroyd A, Michie A . The role of mTOR-mediated signaling in the regulation of cellular migration. Immunol Lett. 2018; 196:74-79. DOI: 10.1016/j.imlet.2018.01.015. View

Wang W, Wang Z, Chen S, Zang X, Miao J . Interleukin-1β/nuclear factor-κB signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis. J Cell Biochem. 2019; 120(2):1763-1772. DOI: 10.1002/jcb.27477. View

10.

Soghli N, Ferns G, Sadeghsoltani F, Qujeq D, Yousefi T, Vaghari-Tabari M . MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity. Biochem Pharmacol. 2022; 201:115094. DOI: 10.1016/j.bcp.2022.115094. View

11.

Liu M, Liu F, Li Y, Yin J, Gao Y, Wang X . Ginsenoside Rg5 Inhibits Human Osteosarcoma Cell Proliferation and Induces Cell Apoptosis through PI3K/Akt/mTORC1-Related LC3 Autophagy Pathway. Oxid Med Cell Longev. 2021; 2021:5040326. PMC: 8257372. DOI: 10.1155/2021/5040326. View

12.

Wang T, Wang H, Peng A, Luo Q, Liu Z, Zhou R . Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro. Biochem Biophys Res Commun. 2013; 440(2):229-34. DOI: 10.1016/j.bbrc.2013.09.024. View

13.

Lv C, Hao Y, Tu G . MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway. Tumour Biol. 2016; 37(7):9333-42. DOI: 10.1007/s13277-016-4807-6. View

14.

Yu W, Chen P, Chen F, Ding S, Pan X . MicroRNA-744 promotes proliferation of osteosarcoma cells by targeting PTEN. Mol Med Rep. 2020; 21(5):2276-2282. DOI: 10.3892/mmr.2020.11030. View

15.

Fan H, Wang S, Shi Y, Sun J . MicroRNA-340-5p inhibits the malignant phenotypes of osteosarcoma by directly targeting NRF2 and deactivating the PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 2021; 25(10):3661-3669. DOI: 10.26355/eurrev_202105_25932. View

16.

Sun H, Lesche R, Li D, Liliental J, Zhang H, Gao J . PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A. 1999; 96(11):6199-204. PMC: 26859. DOI: 10.1073/pnas.96.11.6199. View

17.

Hu X, Li L, Lu Y, Yu X, Chen H, Yin Q . miRNA-21 inhibition inhibits osteosarcoma cell proliferation by targeting PTEN and regulating the TGF-β1 signaling pathway. Oncol Lett. 2018; 16(4):4337-4342. PMC: 6144926. DOI: 10.3892/ol.2018.9177. View

18.

Cui Y, Dong Y . ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway. Aging (Albany NY). 2022; 14(18):7505-7516. PMC: 9550259. DOI: 10.18632/aging.204296. View

19.

Yao P, Ni Y, Liu C . Long Non-Coding RNA 691 Regulated PTEN/PI3K/AKT Signaling Pathway in Osteosarcoma Through miRNA-9-5p. Onco Targets Ther. 2020; 13:4597-4606. PMC: 7250307. DOI: 10.2147/OTT.S249827. View

20.

Zu D, Dong Q, Chen S, Chen Y, Yao J, Zou Y . miRNA-331-3p Affects the Proliferation, Metastasis, and Invasion of Osteosarcoma through SOCS1/JAK2/STAT3. J Oncol. 2022; 2022:6459029. PMC: 9529391. DOI: 10.1155/2022/6459029. View